George Magrath, Chief Executive Officer at Ocuphire Pharma, Inc. (OCUP), bought 5,000 shares at $1.75 ($9K) on 2024-05-17, disclosed to the SEC on 2024-05-21.
Open-market purchase of $9k OCUP by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| IRD | SELL | 2026-03-18 | $255K | — | Filing → |
| IRD | BUY | 2024-12-30 | $98K | — | Filing → |
| IRD | BUY | 2024-11-19 | $192K | — | Filing → |